Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Seminars in Oncology|September 25, 2016
Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cellsLihua Wang, Priya Balasubramanian, Alice P Chen, et al.Journal of the American Academy of Dermatology|April 17, 2012
Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0Alice P Chen, Ann Setser, Milan J Anadkat, et al.Cancer|October 22, 2025
Measuring the multidimensional aspects of tolerabilitySandra A Mitchell, Rachel D Altshuler, Diane C St Germain, et al.Oncotargets and Therapy|March 3, 2022
PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway ComponentsGeraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, et al.The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.The Oncologist|June 2, 2018
A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and SarcomasRobert Meehan, Shivaani Kummar, Khanh Do, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid TumorsKhanh Do, Deborah Wilsker, Jiuping Ji, et al.Cell Cycle (Georgetown, Tex.)|November 22, 2011
Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agentDiana Nguyen, Maria Zajac-Kaye, Larry Rubinstein, et al.The Prostate|September 21, 2002
Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancerJames Gulley, Alice P Chen, William Dahut, et al.Journal of the National Cancer Institute|February 10, 2015
Application of molecular profiling in clinical trials for advanced metastatic cancersShivaani Kummar, P Mickey Williams, Chih-Jian Lih, et al.Pageof 11